l -asparaginase and 6-diazo-5-oxo- l -norleucine synergistically inhibit the growth of glioblastoma cells

ConclusionThe results suggest that the combination ofl-asparaginase and DON could be a new therapeutic option for patients with glioblastoma.

Source: Journal of Neuro-Oncology - January 31, 2020 Category: Cancer & Oncology Source Type: research